高尔基体蛋白73的生物学特征及在肝纤维化和肝硬化中的诊断价值

李佳娜; 郑瑞琦; 李娜; 胡玉琳

doi:10.3969/j.issn.1001-5256.2019.06.040

高尔基体蛋白73的生物学特征及在肝纤维化和肝硬化中的诊断价值

DOI: 10.3969/j.issn.1001-5256.2019.06.040

1. 吉林大学第一医院肝胆胰内科
2. 淄博妇幼保健院重症监护室

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1680
- HTML全文浏览量: 41
- PDF下载量: 227
- 被引次数: 0
出版历程
- 收稿日期: 2018-12-07
- 出版日期: 2019-06-20

The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis

Department of Hepatology, The First Hospital of Jilin University

摘要

摘要: 肝纤维化是慢性肝病发展至肝硬化的必经阶段,肝硬化是各种慢性肝病的终末期改变,其早期诊断对及时治疗和预后非常重要。目前,肝纤维化和肝硬化的诊断方法主要包括肝活组织检查、超声、CT和MRI等。肝活组织检查是诊断肝纤维化及肝硬化程度的金标准,但由于其侵袭性及样本误差,临床应用受到限制。常规的非侵入性措施不能满足肝纤维及肝硬化的诊断要求。因此,寻找一种新的肝纤维化及肝硬化血清学标志物已成为研究热点。相关研究表明,血清高尔基体蛋白73是一种可用于肝纤维化及肝硬化诊断的血清标志物,有较大的临床应用价值。对目前临床上常用的肝纤维化和肝硬化诊断方法进行了陈述,并阐述了高尔基体蛋白73的生物学特征及其在肝纤维化及肝硬化诊断中的价值。
- 肝硬化 /
- 高尔基体蛋白73 /
- 诊断 /
- 综述
Abstract: Liver fibrosis is a necessary stage in the development of chronic liver diseases to liver cirrhosis. Liver cirrhosis is the end-stage change of various chronic liver diseases, and early diagnosis of liver fibrosis has an important value in timely treatment and prognosis. At present, liver biopsy, ultrasound, computed tomography, and magnetic resonance imaging are the main diagnostic methods for liver fibrosis and cirrhosis. Liver biopsy is the gold standard for the diagnosis of liver fibrosis and cirrhosis, but its clinical application is limited by invasiveness and sample error. Conventional noninvasive methods cannot meet the requirements for the diagnosis of liver fibrosis and cirrhosis.Therefore, searching for new serological markers for liver fibrosis and cirrhosis has become a research hotspot. Related studies have shown that serum Golgi protein 73 (GP73) can be used as a serum marker for the diagnosis of liver fibrosis and cirrhosis and has high clinical value. This article reviews the commonly used methods for the diagnosis of liver fibrosis and cirrhosis and elaborates on the biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis.
- liver cirrhosis /
- Golgi protein 73 /
- diagnosis /
- review

HTML全文

参考文献(30)

[1]LACKNER C, KNISELY AS.Liver biopsy in children and adolescents:Preliminary morphological examinations in diffuse liver disease[J].Pathologe, 2017, 26 (6) :1316-1324.

[2]POORTEN VD, KORK A, LAM T, et al.Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital[J].Intern Med J, 2010, 36 (11) :692-699.

[3]PICCININO F, SAGNELLI E, PASQUALE G, et al.Complications following percutaneous liver biopsy.A multicentre retrospective study on 68, 276 biopsies[J].J Hepatol, 1986, 2 (2) :165-173.

[4]KOCAB M, NORD H, BRANTLEY S, et al.Prospective randomized single-blinded evaluation of adequacy of percutaneous liver biopsy by standard Menghini-type (SM) and spring-loaded-type (SL) needles[J].Gastroenterology, 1998, 114 (4) :A1277.

[5]STOECKHERT E.Liver biopsy:Is it still relevant?[J].Intern Med J, 2010, 36 (11) :689-691.

[6]EMANUELE E.Is biopsy always necessary?Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity[J].Hepatology, 2010, 48 (6) :2086-2087.

[7]HUANG FC.Ultrasound diagnosis for 198 psychiatric patients with fatty liver and result analysis[J].Med J Chin People’s Health, 2014, 26 (24) :25-26. (in Chinese) 黄福春.超声诊断精神科脂肪肝患者198例结果分析[J].中国民康医学, 2014, 26 (24) :25-26.

[8]LIANG W, TANG HL, QUAN XY, et al.Preliminary application of 64-slice spiral CT whole-liver perfusion in hepatocellular carcinoma[J].Chin J Med Imaging Technol, 2007, 23 (5) :707-710. (in Chinese) 梁文, 唐海亮, 全显跃, 等.64层螺旋CT全肝灌注模式成像在肝细胞癌中的初步应用[J].中国医学影像技术, 2007, 23 (5) :707-710.

[9]RONOT M, AHSSEL TV, MICHOUX N, et al.Liver fibrosis in chronic hepatitis C virus infection:Differentiating minimal from intermediate fibrosis with perfusion CT[J].Radiology, 2010, 256 (1) :135-142.

[10]LONG LL, HUANG ZK, DING K, et al.Application value multi-slice spiral CT liver perfusion imaging in the chronic hepatic fibrosis and cirrhosis[J].Chin J Radiol, 2012, 46 (4) :317-321. (in Chinese) 龙莉玲, 黄仲奎, 丁可, 等.多层螺旋CT肝脏灌注成像评价慢性肝纤维化、肝硬化的价值[J].中华放射学杂志, 2012, 46 (4) :317-321.

[11]NIU M, DENG DY, LI YPF, et al.Values of MRE in diagnosis of stages of hepatic fibrosis:A Meta-analysis[J].J Jilin Univ:Med Edit, 2017, 43 (4) :787-793. (in Chinese) 牛猛, 邓大勇, 李云鹏飞, 等.磁共振弹性成像对肝纤维化分级诊断分值的Meta分析[J].吉林大学学报:医学版, 2017, 43 (4) :787-793.

[12]PETITCLERC L, SEBASTIANI G, GILBERT G, et al.Liver fibrosis:Review of current imaging and MRI quantification techniques[J].JMRI, 2017, 45 (5) :1276.

[13]LI ZB, SHAO Q, ZHANG J, et al.Study on the influence of alanine transaminase to the accuracy of hepatic hardness diagnosed by FibroScan[J].Prog Mod Biomed, 2012, 12 (36) :7040-7043. (in Chinese) 李忠斌, 邵清, 张健, 等.丙氨酸转氨酶对FibroScan诊断肝硬度准确性的影响[J].现代生物医学进展, 2012, 12 (36) :7040-7043.

[14]KLADNEY RD, BULLA GA, GUO L, et al.GP73, a novel Golgi-localized protein upregulated by viral infection[J].Gene, 2000, 249 (1) :53-65.

[15]WRIGHT LM, YONG S, PICKEN MM, et al.Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2) [J].Int J Clin Exp Pathol, 2009, 2 (1) :34-47.

[16]KLADENY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.

[17]BACHERT C, FIMMEL C, LINSTEDT AD.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma[J].Traffic, 2010, 8 (10) :1415-1423.

[18] KLADNEY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.

[19]WEI HS, KANG YF, HAO XH, et al.Serum GP73 were increased in patients with fatty liver disease[J].Chin J Exp Clin Virol, 2013, 27 (4) :244-246. (in Chinese) 魏红山, 康艳芳, 郝晓花, 等.肝细胞脂肪变对血清糖蛋白GP73水平的影响[J].中华实验和临床病毒学杂志, 2013, 27 (4) :244-246.

[20]IFTIKHAR R, KLADNEY RD, HAVLIOGLU N, et al.Diseaseand cell-specific expression of GP73 in human liver disease[J].Am J Gastroenterol, 2004, 99 (6) :1087.

[21]MAO Y, YANG H, XU H, et al.Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].Gut, 2010, 59 (12) :1687-1693.

[22]CAO Z, LI Z, WANG H, et al.Algorithm of Golgi protein 73and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection[J].Liver Int, 2017, 37 (11) :1612.

[23]FARCI P, WOLLENBERG K, DIAZ G, et al.Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis[J].Proc Natl Acad Sci U S A, 2012, 109 (36) :14562-14567.

[24] LUO KX, CHEN JJ, LI P.Hepatitis B basic biology and clinical science[M].Beijing:People’s Medical Publishing House, 1997:397. (in Chinese) 洛抗先, 陈金军, 李平.乙型肝炎基础与临床[M].北京:人民卫生出版社, 1997:397.

[25]XU ZJ, PAN XN, WEI KP, et al.Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B[J].Mol Med Rep, 2015, 11 (4) :2644-2652.

[26]XU Z, LIU L, PAN X, et al.Serum Golgi proetopancreatobiliaatein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine, 2015, 94 (12) :e659.

[27]YAO MJ, WANG LJ, GUAN GW, et al.Value of serum Golgi protein 73 in assisting the diagnosis of moderate or severe liver injury in patients with chronic hepatitis B[J].J Clin Hepatol, 2018, 34 (4) :755-759. (in Chinese) 姚明解, 王雷婕, 关贵文, 等.血清高尔基体蛋白73在辅助诊断慢性乙型肝炎患者中度以上肝损伤中的应用[J].临床肝胆病杂志, 2018, 34 (4) :755-759.

[28]WEI H, LI B, ZHANG R, et al.Serum GP73, a marker for evaluating progression in patients with chronic HBV infections[J].PLo S One, 2013, 8 (2) :e53862.

[29]WEISKIRCHEN R, TACKE F.Combining GP73 with liver stiffness measurements:A proof-of-concept for non-invasive fibrosis assessment in antiviral-na6ve HBV patients[J].Liver Int, 2017, 37 (11) :1605.

[30]QIAO Y, CHEN J, LI X, et al.Serum GP73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection[J].Clin Biochem, 2014, 47 (16-17) :216-222.

施引文献

资源附件(0)

访问统计